Loading clinical trials...
Loading clinical trials...
Computed tomography (CT) is the modality of choice to characterize pulmonary arteriovenous malformations (PAVMs) in patients with hereditary haemorrhagic telangiectasia (HHT). The objective of this st...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hospices Civils de Lyon
NCT07414446 · Hereditary Haemorrhagic Telangiectasia, PFO - Patent Foramen Ovale, and more
NCT06193252 · Parkinson Disease, Prodromal Stage, and more
NCT03841422 · Hereditary Haemorrhagic Telangiectasia
NCT07474428 · Hereditary Haemorrhagic Telangiectasia (HHT)
NCT06993142 · Parkinson Disease, Prodromal Stage, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions